ResearcherNihon UniversityNo recent work listed
Hiroyuki Hao
Matched on ORCID iD 0000-0001-9951-0251; OpenAlex author ID A5029215171. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper
Papers 2
- Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline pathway and its antitumor effects. Co-author DOI 10.1097/j.pain.0000000000001997↗
- Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo. Last author DOI 10.1016/j.canlet.2017.03.031↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Makoto Sano · 2 shared papers, 2017–2020 · strength 0.17
- Paper Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline p… DOI 10.1097/j.pain.0000000000001997↗
- Paper Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vi… DOI 10.1016/j.canlet.2017.03.031↗
- Yoshimi Ichimaru · 2 shared papers, 2017–2020 · strength 0.17
- Paper Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline p… DOI 10.1097/j.pain.0000000000001997↗
- Paper Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vi… DOI 10.1016/j.canlet.2017.03.031↗
- Ichie Kajiwara · 1 shared paper, 2020 · strength 0.11
- Takahiro Suzuki · 1 shared paper, 2020 · strength 0.11
- Yukino Oshima · 1 shared paper, 2020 · strength 0.11
- Hideaki Ijichi · 1 shared paper, 2020 · strength 0.11
- Atsushi Masamune · 1 shared paper, 2020 · strength 0.11
- Shinichi Miyairi · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.